NAGENDRAN SUKUMAR sold 4.7% of their position (57.05K shares) of TAYSHA GENE THERAPIES, INC. on the open market
Open‑market sale worth $162.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/22/2025ACC: 0001415889-25-022750
Director
Since Sep 2020
-57.05K
Net shares
Net seller
$162.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
57.05K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−57.05K
Price / share
$2.85
Trade value
$162.60K
% of position
4.7%
8/21/2025
1.22M→1.17M
Total
Net shares
−57.05K
Net value
-$162.60K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/21/2025 | S · Sale | −57.05K | $2.85 | $162.60K | 4.7% | 1.22M | 1.17M |
| Total | −57.05K | -$162.60K | ||||||
Derivative Transactions0
No derivative transactions reported